2019 Liver Failure (Hepatic Insufficiency) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

April 2019 | 256 pages | ID: 2FB55E96949EN
VPAResearch

Abstracts

The global clinical trial report- “2019 Liver Failure (Hepatic Insufficiency) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Liver Failure (Hepatic Insufficiency). It presents in-depth analysis of Liver Failure (Hepatic Insufficiency) clinical trials across markets and companies. The research work is for providing complete understanding into trends in Liver Failure (Hepatic Insufficiency).

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Liver Failure (Hepatic Insufficiency) clinical trials by-

• Current Trial Status
• Type of the trial
• Sponsor Type
• Enrollment Trends
• Region
• Countries
• Trial Phase

The report also identifies the potential drug candidates under development for treatment of Liver Failure (Hepatic Insufficiency)

The research work is prepared through extensive and continuous research on Liver Failure (Hepatic Insufficiency) trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:

• All major trials from 2010 to 2019 and planned trials are included in the report scope.
• Drug candidates currently being researched for administering Liver Failure (Hepatic Insufficiency) patients are identified
• The report includes panorama of Liver Failure (Hepatic Insufficiency) clinical trials across the globe
• Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
• Companies and universities focusing on Liver Failure (Hepatic Insufficiency) clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
• Average Enrollment number, insights into enrollment trends, company wise enrollment are included
• Both interventional and observational studies are analyzed
• News and latest developments for the past one year are presented in the report

Contents

1. TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2. EXECUTIVE SUMMARY

2.1 Liver Failure (Hepatic Insufficiency) Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
  2.2.1 Liver Failure (Hepatic Insufficiency) Clinical Trials by Region
  2.2.2 Average Enrollment of Liver Failure (Hepatic Insufficiency) Clinical Trials
  2.2.3 Companies participating in Trials
  2.2.4 Drugs under Study for Liver Failure (Hepatic Insufficiency) Treatment, 2019

3. REGION WISE LIVER FAILURE (HEPATIC INSUFFICIENCY) CLINICAL TRIALS

3.1 Asia Pacific Liver Failure (Hepatic Insufficiency) Clinical Trials by Country
3.2 Europe Liver Failure (Hepatic Insufficiency) Clinical Trials by Country
3.3 North America Liver Failure (Hepatic Insufficiency) Clinical Trials by Country
3.4 Middle East and Africa Liver Failure (Hepatic Insufficiency) Clinical Trials by Country
3.5 South and Central America Liver Failure (Hepatic Insufficiency) Clinical Trials by Country

4. LIVER FAILURE (HEPATIC INSUFFICIENCY) CLINICAL TRIAL TRENDS

4.1 Start Year wise Liver Failure (Hepatic Insufficiency) Clinical Trials
4.2 Phase wise Liver Failure (Hepatic Insufficiency) Clinical Trials
4.3 Trial Status wise Liver Failure (Hepatic Insufficiency) Clinical Trials
4.4 Trial Type wise Liver Failure (Hepatic Insufficiency) Clinical Trials

5. LIVER FAILURE (HEPATIC INSUFFICIENCY) AVERAGE ENROLLMENT TRENDS

5.1 Average Enrollment in Liver Failure (Hepatic Insufficiency) Trials by Year
5.2 Average Enrollment in Liver Failure (Hepatic Insufficiency) Trials by Phase
5.3 Average Enrollment in Liver Failure (Hepatic Insufficiency) Trials by Status
5.4 Average Enrollment in Liver Failure (Hepatic Insufficiency) Trials by Type of Trial

6. COMPANIES PARTICIPATING IN LIVER FAILURE (HEPATIC INSUFFICIENCY) CLINICAL TRIALS

6.1 Liver Failure (Hepatic Insufficiency) Trials by Sponsor Type
6.2 Liver Failure (Hepatic Insufficiency) Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 TRIAL SNAPSHOTS- PHASE, TYPE, TITLE, LOCATION, START YEAR, COMPLETION YEAR, RECRUITMENT STATUS, ENROLLMENT, PARTICIPATING COUNTRIES, TRIAL LOCATIONS, COMPANY, DRUGS AND OTHER DETAILS

7.1 Liver Failure (Hepatic Insufficiency) Trials- Phase
7.2 Liver Failure (Hepatic Insufficiency) Trials- Phase
7.3 Liver Failure (Hepatic Insufficiency) Trials- Phase
7.4 Liver Failure (Hepatic Insufficiency) Trials- Phase

8. APPENDIX

8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List Of Figures

LIST OF FIGURES

Figure 1: Liver Failure (Hepatic Insufficiency) Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Liver Failure (Hepatic Insufficiency) Clinical Trials and Enrolment
Figure 5: Europe – Country wise Liver Failure (Hepatic Insufficiency) Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Liver Failure (Hepatic Insufficiency) Clinical Trials and Enrolment
Figure 7: North America – Country wise Liver Failure (Hepatic Insufficiency) Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Liver Failure (Hepatic Insufficiency) Clinical Trials and Enrolment
Figure 9: Liver Failure (Hepatic Insufficiency) Clinical Trials by Phase
Figure 10: Liver Failure (Hepatic Insufficiency) Clinical Trials by Trial Status
Figure 11: Liver Failure (Hepatic Insufficiency) Clinical Trials by Type
Figure 12: Liver Failure (Hepatic Insufficiency) Clinical Trials by Sponsor Type
Figure 13: Liver Failure (Hepatic Insufficiency) Clinical Trials by Leading Sponsors
Figure 14: Liver Failure (Hepatic Insufficiency) Average Enrollment by Phase
Figure 15: Liver Failure (Hepatic Insufficiency) Average Enrollment by Trial Status
Figure 16: Liver Failure (Hepatic Insufficiency) Average Enrollment by Type
Figure 17: Liver Failure (Hepatic Insufficiency)- Average Enrolment by Type of Sponsors
Figure 18: Liver Failure (Hepatic Insufficiency)- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

List Of Tables

LIST OF TABLES

Table 1: Liver Failure (Hepatic Insufficiency) Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Liver Failure (Hepatic Insufficiency) Clinical Trials and Enrolment
Table 5: Europe – Country wise Liver Failure (Hepatic Insufficiency) Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Liver Failure (Hepatic Insufficiency) Clinical Trials and Enrolment
Table 7: North America – Country wise Liver Failure (Hepatic Insufficiency) Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Liver Failure (Hepatic Insufficiency) Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Liver Failure (Hepatic Insufficiency) Average Enrollment by Phase
Table 15: Liver Failure (Hepatic Insufficiency) Average Enrollment by Trial Status
Table 16: Liver Failure (Hepatic Insufficiency) Average Enrollment by Type
Table 17: Liver Failure (Hepatic Insufficiency)- Average Enrolment by Type of Sponsors
Table 18: Liver Failure (Hepatic Insufficiency)- Enrolment by Leading Sponsors